Metabolic influences for mutation induction curves after exposure to Sudan-1 and para red

Mutagenesis

Volumn 25, Issue 4, 2010, Pages 327-333

  Johnson, George E ^a   Quick, Emma L ^a   Parry, Elizabeth M ^a   Parry, James M ^a  

^a SWANSEA UNIVERSITY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AZO DYE; CYTOCHROME P450 1A1; CYTOCHROME P450 2A6; CYTOCHROME P450 3A4; HYPOXANTHINE PHOSPHORIBOSYLTRANSFERASE; PARA RED; SUDAN I; UNCLASSIFIED DRUG; 1-PHENYLAZO-2-NAPHTHOL; AZO COMPOUND; CARCINOGEN; COLORING AGENT; CYP2A6 PROTEIN, HUMAN; CYP3A4 PROTEIN, HUMAN; CYTOCHROME P450 1A2; CYTOCHROME P450 3A; MUTAGENIC AGENT; NAPHTHOL DERIVATIVE; UNSPECIFIC MONOOXYGENASE;

AEROBIC METABOLISM; ARTICLE; CELL LINE; CELL POPULATION; CHROMOSOME DAMAGE; CONTROLLED STUDY; CYTOKINESIS; DOSE RESPONSE; GENE MUTATION; GENETIC TRANSFECTION; GENOTOXICITY; HUMAN; HUMAN CELL; INDUCED MUTATION; METABOLISM; METABOLITE; MICRONUCLEUS TEST; MUTAGENIC ACTIVITY; MUTATIONAL ANALYSIS; OXIDATION; PLASMID; PRIORITY JOURNAL; PROTEIN EXPRESSION; CHROMOSOME BREAKAGE; GENETICS; MUTATION; TOXICITY; TUMOR CELL LINE;

ARYL HYDROCARBON HYDROXYLASES; AZO COMPOUNDS; CARCINOGENS; CELL LINE, TUMOR; CHROMOSOME BREAKAGE; COLORING AGENTS; CYTOCHROME P-450 CYP1A2; CYTOCHROME P-450 CYP2A6; CYTOCHROME P-450 CYP3A; DOSE-RESPONSE RELATIONSHIP, DRUG; HUMANS; HYPOXANTHINE PHOSPHORIBOSYLTRANSFERASE; MUTAGENS; MUTATION; NAPHTHOLS;

EID: 77954414068     PISSN: 02678357     EISSN: 14643804     Source Type: Journal    
DOI: 10.1093/mutage/geq009     Document Type: Article

References (46)

1. Mazzetti, M., Fascioli, R., Mazzoncini, I., Spinelli, G., Morelli, I. and Bertoli, A. (2004) Determination of 1-phenylazo-2-naphthol (Sudan I) in chilli powder and in chilli-containing food products by GPC clean-up and HPLC with LC/MS confirmation. Food Addit. Contam., 21, 935-941. (Pubitemid 39599989)
2. FSA. Sudan I Consolidated Product List From February 2005 Recall. http://www.food.gov.uk/safereating/chemsafe/sudani/sudanlistno (accessed February 22, 2010).
3. Stiborova, M., Martinek, V., Rydlova, H., Hodek, P. and Frei, E. (2002) Sudan I is a potential carcinogen for humans: evidence for its metabolic activation and detoxication by human recombinant cytochrome P450 1A1 and liver microsomes. Cancer Res., 62, 5678-5684. (Pubitemid 35204721)
4. Milvy, P. and Kay, K. (1978) Mutagenicity of u9 major graphic arts and printing dyes. J. Toxicol. Environ. Health, 4, 31-36. (Pubitemid 8301943)
5. Stiborova, M., Martinek, V., Schmeiser,H. H.and Frei,E. (2006) Modulation of CYP1A1-mediated oxidation of carcinogenic azo dye Sudan I and its binding to DNA by cytochrome b5. Neuro Endocrinol. Lett., 2, 35-39. (Pubitemid 46534333)
6. Mansour, H., Corroler, D., Barillier, D., Ghedira, K., Chekir, L. and Mosrati, R. (2007) Evaluation of genotoxicity and pro-oxidant effect of the azo dyes: acids yellow 17, violet 7 and orange 52, and of their degradation products by Pseudomonas putida mt-2. Food Chem. Toxicol., 45, 1670-1677. (Pubitemid 47102504)
7. Percy, A. J., Moore, N. and Chipman, J. K. (1989) Formation of nuclear anomalies in rat intestine by benzidine and its biliary metabolites. Toxicology, 57, 217-223. (Pubitemid 19164725)
8. Medvedev, Z. A., Crowne, H. M. and Medvedeva, M. N. (1988) Age related variations of hepatocarcinogenic effect of azo dye (3#-MDAB) as linked to the level of hepatocyte polyploidization. Mech. Ageing Dev., 46, 159-174.
9. Cameron, T. P., Hughes, T. J., Kirby, P. E., Fung, V. A. and Dunkel, V. C. (1987) Mutagenic activity of 27 dyes and related chemicals in the salmonella/microsome and mouse lymphoma TK\+/-assays. Mutat. Res., 189, 223-261.
10. Matsuoka, A., Tada, A., Terao, Y., Nukaya, H., Onfelt, A. and Wakabayashi, K. (2001) Chromosomal effects of newly identified water pollutants PBTA-1 and PBTA-2 and their possible mother compounds (azo dyes) and intermediates (non-ClPBTAs) in two Chinese hamster cell lines. Mutat. Res., 493, 75-85. (Pubitemid 32539431)
11. An, Y., Jiang, L., Cao, J., Geng, C. and Zhong, L. (2007) Sudan I induces genotoxic effects and oxidative DNA damage in HepG2 cells. Mutat. Res., 627, 164-170. (Pubitemid 46097494)
12. Knasmuller, S., Parzefall, W., Sanyal, R. et al. (1998) Use of metabolically competent human hepatoma cells for the detection of mutagens and antimutagens. Mutat. Res., 402, 185-202. (Pubitemid 28440274)
13. Tennant, R. W., Margolin, B. H., Shelby, M. D. et al. (1987) Prediction of chemical carcinogenicity in rodents from in vitro genetic toxicity assays. Science, 236, 933-941.
14. McGregor, D. B., Brown, A. G., Howgate, S., McBride, D., Riach, C. and Caspary, W. J. (1991) Responses of the L5178Y mouse Lymphoma cell forward mutation assay. V: 27 coded chemicals. Environ. Mol. Mutagen., 17, 196-219.
15. European Medicines Agency. CHMP ASSESSMENT REPORT FOR VIRACEPT: Assessment Report on the lifting of the suspension of the Marketing Authorisation for Viracept as adopted by the CHMP. EMEA/CHMP/492059/2007. London: European Medicines Agency, 2007.
16. Chequer, F. M. D., Angeli, J. P. F., Ferraz, E. R. A., Tsuboy, M. S., Marcarini, J. C., Mantovani, M. S. andde Oliveira, D. P. (2009) The azo dyes Disperse Red 1 and Disperse Orange 1 increase the micronuclei frequencies in human lymphocytes and in HepG2 cells. Mutat. Res., 676, 83-86.
17. Stiborova, M., Asfaw, B., Frei, E., Schmeiser, H. H. and Wiessler, M. (1995) Benzenediazonium ion derived from Sudan I forms an 8-(phenylazo)guanine adduct in DNA. Chem. Res. Toxicol., 8, 489-498.
18. Bartsch, H. (1981) Metabolic activation of aromatic amines and azo dyes. IARC Sci. Publ., 40, 13-30.
19. Federal Institute for Risk Assessment (2003) Dyes Sudan I to IV in food. http://www.bfr.bund.de/cm/245/dyes-sudan-I-IV.pdf (accessed February 22, 2010).
20. Elhajouji, A., Tibaldi, F. and Kirsch-Volders, M. (1997) Indication for thresholds of chromosome non-disjunction versus chromosome lagging induced by spindle inhibitors in vitro in human lymphocytes. Mutagenesis, 12, 133-140. (Pubitemid 27234648)
21. Elhajouji, A., Van Hummelen, P. and Kirsch-Volders, M. (1995) Indications for a threshold of chemically-induced aneuploidy in vitro in human lymphocytes. Environ. Mol. Mutagen., 26, 292-304. (Pubitemid 26035493)
22. Kirsch-Volders, M., Vanhauwaert, A., Eichenlaub-Ritter, U. and Decordier, I. (2003) Indirect mechanisms of genotoxicity. Toxicol. Lett., 140-141, 63-74. (Pubitemid 36378924)
23. COM. (2001) Statement on risk assessment of in-vivo mutagens (and genotoxic carcinogens). In Committee on Mutagenicity. COM, http://www. advisorybodies.doh.gov.uk/Com/comivm.htm (accessed February 22, 2010). London: Department of Health.
24. Lynch, A., Harvey, J., Aylott, M., Nicholas, E., Burman, M., Siddiqui, A., Walker, S. and Rees, R. (2003) Investigations into the concept of a threshold for topoisomerase inhibitor-induced clastogenicity. Mutagen-esis, 18, 345-353 (Pubitemid 36850202)
25. NTP. (1993) NTP Technical Report on the Toxicology and Carcinogenesis studies of p-nitroaniline (CAS 100-01-6) in B6C3F Mice (Gavage Studies). TR 418. NIH Publication. 93-3149 Research Triangle Park, NC: NTP.
26. Doak, S. H., Brüsehafer, K., Dudley, E., Quick, E., Johnson, G., Newton, R. P. and Jenkins, G. J. S. (2008) No-observed effect levels are associated with up-regulation of MGMT following MMS exposure. Mutat. Res., 648, 9-14.
27. Doak, S. H., Jenkins, G. J., Johnson, G. E., Quick, E., Parry, E. M. and Parry, J. M. (2007) Mechanistic influences for mutation induction curves after exposure to DNA-reactive carcinogens. Cancer Res., 67, 3904-3911. (Pubitemid 46762179)
28. Marsden, D. A., Jones, D. J. L., Britton, R. G., Ognibene, T., Ubick, E., Johnson, G. E., Farmer, P. B. and Brown, K. (2009) Dose-response relationships for N7-(2-hydroxyethyl)guanine induced by low-dose [14C]ethylene oxide: evidence for a novel mechanism of endogenous adduct formation. Cancer Res., 69, 3052-3059.
29. Gocke, E., Ballantyne, M., Whitwell, J. and Müller, L. (2009) MNT and Muta(TM) Mouse studies to define the in vivo dose response relations of the genotoxicity of EMS and ENU. Toxicol. Lett., 190, 286-297.
30. Gocke, E. and Müller, L. (2009) In vivo studies in the mouse to define a threshold for the genotoxicityof EMS and ENU. Mutat. Res., 678, 101-107.
31. Kirkland, D., Pfuhler, S., Tweats, D. et al. (2007) How to reduce false positive results when undertaking in vitro genotoxicity testing and thus avoid unnecessary follow-up animal tests: report of an ECVAM Workshop. Mutat. Res., 628, 31-55. (Pubitemid 46316835)
32. Crespi, C. L., Gonzalez, F. J., Steimel, D. T., Turner, T. R., Gelboin, H. V., Penman, B. W. and Langenbach, R. (1991) A metabolically competent human cell line expressing five cDNAs encoding procarcinogen-activating enzymes: application to mutagenicity testing. Chem. Res. Toxicol., 4, 566-572.
33. Crespi, C. L., Langenbach, R. and Penman, B. W. (1990) The development of a panel of human cell lines expressing specific human cytochrome P450 cDNAs. Prog. Clin. Biol. Res., 340B, 97-106
34. Gentest (1994) AHH-1 TK\+/-Human Lymphoblastoid Cells. Routine cell culture, metabolite production and gene-locus mutation assay. Procedures for use. Gentest corporation, Woburn, MA, USA, 90-91(Version 9).
35. Freedman, H. J., Gurtoo, H. L., Minowada, J., Paigen, B. and Vaught, J. B. (1979) Aryl hydrocarbon hydroxylase in a stable human B-lymphocyte cell line, RPMI-1788, cultured in the absence of mitogen. Cancer Res., 39, 4605-4611. (Pubitemid 10198639)
36. Freedman, H. J., Parker, N. B., Marinello, A. J., Gurtoo, H. L. and Minowada, J. (1979) Induction, inhibition, and biological properties of aryl hydrocarbon hydroxylase in a stable human B-lymphocyte cell line, RPMI-1788. Cancer Res., 39, 4612-4619. (Pubitemid 10198639)
37. Crespi, C. L. and Thilly, W. G. (1984) Assay for gene mutation in a human lymphoblast line, AHH-1, competent for xenobiotic metabolism. Mutat. Res., 128, 221-230.
38. Woodruff, N. W., Durant, J. L., Donhoffner, L. L., Penman, B. W. and Crespi, C. L. (2001) Human cell mutagenicity of chlorinated and unchlorinated water and the disinfection byproduct 3-chloro-4-(dichlor-omethyl)-5-hydroxy- 2(5H)-furanone (MX). Mutat. Res., 495, 157-168.
39. Fenech, M. (2000) The in vitro micronucleus technique. Mutat. Res., 455, 81-95.
40. Kirsch-Volders, M., Sofuni, T., Aardema, M., Albertini, S., Eastmond, D., Fenech, M., Ishidate, J. M., Kirchner, S. and Lorge, E. (2004) Corrigendum to "Report from the in vitro micronucleus assay working group". Mutat. Res., 564, 97-100.
41. Furth, E. E., Thilly, W. G., Penman, B. W., Liber, H. L. and Rand, W. M. (1981) Quantitative assay for mutation in diploid human lymphoblasts using microtiter plates. Anal. Biochem., 110, 1-8.
42. Stiborova, M., Martinek, V., Rydlova, H., Koblas, T. and Hodek, P. (2005) Expression of cytochrome P450 1A1 and its contribution to oxidation of a potential human carcinogen 1-phenylazo-2-naphthol (Sudan I) in human livers. Cancer Lett., 220, 145-154. (Pubitemid 40568771)
43. Stiborova, M., Frei, E. and Schmeiser, H. H. (1992) Comparison of cytochrome P-450-and peroxidase-mediated activations of carcinogenic azo dyes and N-nitrosamines. Gen. Physiol. Biophys., 11, 489-498.
44. Stiborova, M., Asfaw, B., Anzenbacher, P., Leseticky, L. and Hodek, P. (1988) The first identification of the benzenediazonium ion formation from a non-aminoazo dye, 1-phenylazo-2-hydroxynaphthalene (Sudan I) by microsomes of rat livers. Cancer Lett., 40, 319-326.
45. Stiborova, M., Asfaw, B., Anzenbacher, P. and Hodek, P. (1988) A new way to carcinogenicity of azo dyes: the benzenediazonium ion formed from a non-aminoazo dye, 1-phenylazo-2-hydroxynaphthalene(Sudan I) by microsomal enzymes binds to deoxyguanosine residues of DNA. Cancer Lett., 40, 327-333.
46. MacGregor, J. T. (2009) The ILSI-HESI project committee on the relevance and follow-up of positive results in vitro genetic toxicity testing (IVGT): Quantitative aspects of genotoxicity risk assessment., in ICEM/EEMS. EEMS, Firenze, Italy, 65IN049.